Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Our aim is to observe whether anti-TNF-alpha regimen will effect serum adiponectin concentration after myocardial infarction/reperfusion and also beneficial for the patients undergoing percutaneous coronary intervention (PCI).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xijing Hospital
• Treatments: Etanercept

Criteria

Inclusion Criteria:

• patients with acute ST segment elevated myocardial infarction in 12h

Exclusion Criteria:

• Cardiogenic shock

• old myocardial infarction

• other causes of cardiac insufficiency

• tumor

• Coronary anatomy unsuitable for PCI or Need of emergency coronary artery by-pass grafting

• Pregnancy